Efficacy and safety of fumaric acid esters in young patients aged 10 to 17 years with moderate-to-severe plaque psoriasis - A randomised, double-blinded, placebo-controlled trial.

CONCLUSIONS: FAE administered over a period of 20 weeks demonstrated a response that was statistically significant and clinically meaningful better to placebo. Application up to 40 weeks was generally well tolerated. However, further studies are required.
PMID: 33332574 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - December 17, 2020 Category: Dermatology Authors: Hamm H, Wilsmann-Theis D, Tsianakas A, Gambichler T, Taipale K, Lauterbach J, Freudensprung U, Makepeace C, KIFUderm study investigators Tags: Br J Dermatol Source Type: research